DENAGARD VET 450 mg/g rakeet Finland - Finnish - Fimea (Suomen lääkevirasto)

denagard vet 450 mg/g rakeet

elanco gmbh - tiamulini hydrogenofumaras - rakeet - 450 mg/g - tiamuliini

DENAGARD VET 20 mg/g jauhe Finland - Finnish - Fimea (Suomen lääkevirasto)

denagard vet 20 mg/g jauhe

elanco gmbh - tiamulini hydrogenofumaras - jauhe - 20 mg/g - tiamuliini

DYNAMUTILIN VET 450 mg/g jauhe Finland - Finnish - Fimea (Suomen lääkevirasto)

dynamutilin vet 450 mg/g jauhe

novo nordisk a/s - tiamulini hydrogenofumaras - jauhe - 450 mg/g - tiamuliini

Caremast vet 600 mg intramammaarisuspensio Finland - Finnish - Fimea (Suomen lääkevirasto)

caremast vet 600 mg intramammaarisuspensio

vetcare oy - procaine benzylpenicillin monohydrate - intramammaarisuspensio - 600 mg - prokaiinipenisilliini

Dimethyl fumarate Mylan European Union - Finnish - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma European Union - Finnish - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Teva European Union - Finnish - EMA (European Medicines Agency)

dimethyl fumarate teva

teva gmbh - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Accord European Union - Finnish - EMA (European Medicines Agency)

dimethyl fumarate accord

accord healthcare s.l.u. - dimetyylifumaraatti - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunosuppressantit - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).

Dimethyl fumarate Neuraxpharm European Union - Finnish - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - dimetyylifumaraatti - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Vumerity European Union - Finnish - EMA (European Medicines Agency)

vumerity

biogen netherlands b.v. - diroximel fumarate (biib098) - multippeliskleroosi, relapsoiva-remittoiva - immunosuppressantit - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).